COMPASS PATHWAYS PLC Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period
COMPASS PATHWAYS PLC (CMPS) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period of 2.29 million shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-24.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod · last filed 2026-03-24
- COMPASS PATHWAYS PLC share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2024-03-31 was 768.84K shares, a 485.34% increase year-over-year.
- COMPASS PATHWAYS PLC share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2023-12-31 was 29.94K shares, a 51.90% decline year-over-year.
- COMPASS PATHWAYS PLC share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2023-09-30 was 141.68K shares, a 144.11% increase year-over-year.
- COMPASS PATHWAYS PLC share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2023-06-30 was 214.54K shares, a 20.17% decline year-over-year.
- COMPASS PATHWAYS PLC share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2025 was 2.29M shares, a 50.70% increase from fiscal 2024.
- COMPASS PATHWAYS PLC share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2024 was 1.52M shares, a 193.51% increase from fiscal 2023.
- COMPASS PATHWAYS PLC share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2023 was 517.52K shares, a 7.63% increase from fiscal 2022.
- COMPASS PATHWAYS PLC share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2022 was 480.83K shares, a 53.21% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 12 month |
|---|---|---|---|---|
| 2025-12-31 | 2.29M shares 10-K · filed 2026-03-24 | |||
| 2024-12-31 | 1.52M shares 10-K · filed 2025-02-27 | |||
| 2024-03-31 | 768.84K shares 10-Q · filed 2024-05-08 | 798.78K shares derived: sum of 2 quarters · filed 2024-05-08 | 940.47K shares derived: sum of 3 quarters · filed 2024-05-08 | 1.16M shares derived: sum of 4 quarters · filed 2024-05-08 |
| 2023-12-31 | 29.94K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | 171.62K shares derived: sum of 2 quarters · filed 2024-02-29 | 386.17K shares derived: sum of 3 quarters · filed 2024-02-29 | 517.52K shares 10-K · filed 2024-02-29 |
| 2023-09-30 | 141.68K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | 356.23K shares derived: sum of 2 quarters · filed 2023-11-02 | 487.58K shares 10-Q · filed 2023-11-02 | 549.82K shares derived: sum of 4 quarters · filed 2023-11-02 |
| 2023-06-30 | 214.54K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | 345.89K shares 10-Q · filed 2023-08-03 | 408.14K shares derived: sum of 3 quarters · filed 2023-08-03 | 466.18K shares derived: sum of 4 quarters · filed 2023-08-03 |
| 2023-03-31 | 131.35K shares 10-Q · filed 2023-05-11 | 193.59K shares derived: sum of 2 quarters · filed 2023-05-11 | 251.63K shares derived: sum of 3 quarters · filed 2023-05-11 | 520.38K shares derived: sum of 4 quarters · filed 2023-05-11 |
| 2022-12-31 | 62.24K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | 120.28K shares derived: sum of 2 quarters · filed 2023-02-28 | 389.03K shares derived: sum of 3 quarters · filed 2023-02-28 | 480.83K shares 10-K · filed 2023-02-28 |
| 2022-09-30 | 58.04K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | 326.79K shares derived: sum of 2 quarters · filed 2022-11-03 | 418.59K shares 10-Q · filed 2022-11-03 | |
| 2022-06-30 | 268.75K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | 360.55K shares 10-Q · filed 2022-08-04 | ||
| 2022-03-31 | 91.80K shares 10-Q · filed 2022-05-10 | |||
| 2021-12-31 | 313.83K shares 10-K · filed 2023-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |